Compare SUN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | LEGN |
|---|---|---|
| Founded | 1886 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 5.9B |
| IPO Year | N/A | 2020 |
| Metric | SUN | LEGN |
|---|---|---|
| Price | $52.18 | $21.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $63.75 | ★ $69.58 |
| AVG Volume (30 Days) | 411.9K | ★ 2.6M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 7.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.93 | N/A |
| Revenue | ★ $21,870,000,000.00 | $909,045,000.00 |
| Revenue This Year | $2.83 | $68.83 |
| Revenue Next Year | $10.99 | $51.27 |
| P/E Ratio | $17.83 | ★ N/A |
| Revenue Growth | N/A | ★ 74.75 |
| 52 Week Low | $47.98 | $21.19 |
| 52 Week High | $59.88 | $45.30 |
| Indicator | SUN | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 25.47 |
| Support Level | $52.03 | $21.19 |
| Resistance Level | $52.99 | $28.97 |
| Average True Range (ATR) | 0.98 | 1.27 |
| MACD | -0.34 | -0.26 |
| Stochastic Oscillator | 1.88 | 9.13 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.